Market Research
Europe’s Medical Cannabis Sector Shows Steady Expansion
LOS ANGELES – Prohibition Partners’ report indicates that Europe's medical ...
Tilray Executes 1-for-10 Reverse Stock Split to Trim Shares and Cut Costs
NEW YORK – Tilray Brands Inc. confirmed it will carry ...
New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients
ALBANY – Governor Kathy Hochul signed a bill into law ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options
CHARLESTON – Elevated prices in West Virginia's medical Cannabis system continue to steer registered patients toward recreational outlets in Ohio, Maryland, and Michigan, where products sell at fractions of the cost despite legal barriers to ...
